Langerhans cell histiocytosis

Clinical and Translational Oncology

Volumn 10, Issue 11, 2008, Pages 688-696

  Blesa, Joan Manel Gasent ^a   Candel, Vicente Alberola ^a   Vercet, Carlos Solano ^b   Canales, Juan Laforga ^a   Semler, Christof ^c,d   Antolí, M Rosa Pérez ^d   Rodríguez Galindo, Carlos ^e  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d Centro Clínico Euroclínica Jàvea   (Spain)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Adult; Langerhans's cell histiocytosis; Review

Indexed keywords

CYTOKINE; CYTOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; CELL CLONE; CHILD; DRUG COMBINATION; FEMALE; HISTIOCYTOSIS X; HUMAN; IMMUNOLOGY; LANGERHANS CELL; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; STATISTICS;

ADOLESCENT; ADULT; AGED; CHILD; CLONE CELLS; COMBINED MODALITY THERAPY; CYTOKINES; CYTOSTATIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LANGERHANS CELLS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; ORGAN SPECIFICITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; YOUNG ADULT;

EID: 84875039309     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-008-0275-9     Document Type: Article

References (89)

1. Arico M, Egeler RM (1998) Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12:247-258
2. Willman CL, Busque L, Griffith BB et al (1994) Langerhans' cell histiocytosis (histiocytosis X)-a clonal proliferative disease. N Engl J Med 331: 154-160
3. Broadbent V, Pritchard J, Davies EG (1984) Spontaneous remission of multisystem histiocytosis X. Lancet 1:253-254
4. Kannourakis G, Abbas A (1994) The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Br J Cancer 70[Suppl 23]:S37-S40
5. Bernard F, Thomas C, Bertrand Y et al (2005) Multicentre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with hematological dysfunction. Eur J Cancer 41:2682-2689
6. Writing Group of the Histiocyte Society (1987) Histiocytosis syndromes in children. Lancet 1:208
7. Favara BE, Feller AC, Pauli M et al (1997) Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 29:157
8. Favara BE (1991) Langerhans' cell histiocytosis pathobiology and pathogenesis. Semin Oncol 18:3
9. Seiji M, Shimao K, Fitzpatrick TB, Birbeck MS (1961) The site of biosynthesis of mammalian tyrosinase. J Invest Dermatol 37:359
10. Valladeau J, Ravel O, Dezutter-Dambuyant C et al (2000) Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12:71
11. Geissmann F, Lepelletier Y, Fraitag S et al (2001) Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 97:1241
12. Jordan MB, McClain KL, Yan X et al (2005) Anti-CD52 antibody, alemtuzumab, binds to Langerhans cells in Langerhans cell histiocytosis. Pediatr Blood Cancer 44:251
13. Egeler RM, Favara BE, van Meurs M et al (1999) Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 94:4195
14. Egeler RM, Favara BE, Laman JD, Claassen E (2000) Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions. Eur J Cancer 36:2105
15. Ishii R, Morimoto A, Ikushima S et al (2006) High serum values of soluble CD154, IL-2 receptor, RANKL and osteoprotegerin in Langerhans cell histiocytosis. Pediatr Blood Cancer 47:194
16. Annels NE, Da Costa CE, Prins FA et al (2003) Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J Exp Med 197:1385
17. De Filippi P, Badulli C, Cuccia M et al (2006) Specific polymorphisms of cytokine genes are associated with different risks to develop single-system or multi-system childhood Langerhans cell histiocytosis. Br J Haematol 132:784
18. Fleming MD, Pinkus JL, Alexander SW et al (2003) Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood 101:2473
19. Schouten B, Egeler RM, Leenen PJ et al (2002) Expression of cell cycle-related gene products in Langerhans cell histiocytosis. J Pediatr Hematol Oncol 24:727
20. Marchal J, Kambouchner M, Tazi A et al (2004) Expression of apoptosis-regulatory proteins in lesions of pulmonary Langerhans cell histiocytosis. Histopathology 45:20
21. Dina A, Zahava V, Iness M (2005) The role of vascular endothelial growth factor in Langerhans cell histiocytosis. J Pediatr Hematol Oncol 27:62
22. Schultz C, Klouche M, Friedrichsdorf S et al (1998) Langerhans cell histiocytosis in children: does soluble interleukin-2-receptor correlate with both disease extent and activity? Med Pediatr Oncol 31:61
23. Rosso DA, Roy A, Zelazko M, Braier JL (2002) Prognostic value of soluble interleukin 2 receptor levels in Langerhans cell histiocytosis. Br J Hae-matol 117:54
24. Rolland A, Guyon L, Gill M et al (2005) Increased blood myeloid dendritic cells and dendritic cell-poietins in Langerhans cell histiocytosis. J Immunol 174:3067
25. Bernstrand C, Carstensen H, Jakobsen B et al (2003) Immunogenetic heterogeneity in singlesystem and multisystem Langerhans cell histiocytosis. Pediatr Res 54:30
26. McClain KL, Laud P, Wu WS, Pollack MS (2003) Langerhans cell histiocytosis patients have HLA Cw7 and DR4 types associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoter. Med Pediatr Oncol 41:502
27. Scappaticci S, Danesino C, Rossi E et al (2000) Cytogenetic abnormalities in PHA-stimulated lymphocytes from patients with Langerhans cell histiocytosis. AIEOP-Istiocitosi Group. Br J Haematol 111:258
28. Leahy MA, Krejci SM, Friednash M et al (1993) Human herpes virus 6 is present in lesions of Langerhans cell histiocytosis. J Invest Dermatol 101:642
29. Glotzbecker MP, Carpentieri DF, Dormans JP (2004) Langerhans cell histiocytosis: a primary viral infection of bone? Human herpes virus 6 latent protein detected in lymphocytes from tissue of children. J Pediatr Orthop 24:123
30. McClain K, Jin H, Gresik V, Favara B (1994) Langerhans cell histiocytosis: lack of a viral etiology. Am J Hematol 47:16
31. Shimakage M, Sasagawa T, Kimura M et al (2004) Expression of Epstein-Barr virus in Langerhans' cell histiocytosis. Hum Pathol 35:862
32. Baumgartner I, von Hochstetter A, Baumert B et al (1997) Langerhans'-cell histiocytosis in adults. Med Pediatr Oncol 28:9
33. Malpas JS, Norton AJ (1996) Langerhans cell histiocytosis in the adult. Med Pediatr Oncol 27:540
34. Howarth DM, Gilchrist GS, Mullan BP et al (1999) Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 85:2278
35. Islinger RB, Kuklo TR, Owens BD et al (2000) Langerhans' cell histiocytosis in patients older than 21 years. Clin Orthop Relat Res 379:231-235
36. Gotz G, Fichter J (2004) Langerhans'-cell histiocytosis in 58 adults. Eur J Med Res 9:510
37. Schonfeld N, Frank W, Wenig S et al (1993) Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 60:38
38. Casolaro MA, Bernaudin JF, Saltini C et al (1988) Accumulation of Langerhans' cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 137:406-411
39. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J (1992) GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258-261
40. Aguayo SM, Kane MA, King TE Jr. et al (1989) Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers. J Clin Invest 84:1105-1113
41. Del Rio M, Hernanz A, de la Fuente M (1994) Bombesin, gastrin-releasing peptide, and neuromedin C modulate murine lymphocyte proliferation through adherent accessory cells and activate protein kinase C. Peptides 15:15-22
42. Lemaire I (1991) Bombesin-related peptides modulate interleukin-1 production by alveolar macrophages. Neuropeptides 20:217-223
43. Youkeles LH, Grizzanti JN, Liao Z et al (1995) Decreased tobacco-glycoprotein-induced lymphocyte proliferation in vitro in pulmonary eo si-nophilic granuloma. Am J Respir Crit Care Med 151:145-150
44. Francus T, Klein RF, Staiano-Coico L et al (1988) Effects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells. J Immunol 140:1823-1829 [erratum 140:4413
45. Tazi A, Moreau J, Bergeron A et al (1999) Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J Immunol 163:3511
46. Yousem SA, Colby TV, Chen YY et al (2001) Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 25:630
47. Travis WD, Borok Z, Roum JH et al (1993) Pulmonary Langerhans cell granulomatosis (histiocytosis X): a clinicopathologic study of 48 cases. Am J Surg Pathol 17:971
48. Delobbe A, Durieu J, Duhamel A, Wallaert B (1996) Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Eur Respir J 9:2002
49. Crausman RS, Jennings CA, Tuder RM et al (1996) Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med 153:426
50. Diette GB, Scatarige JC, Haponik EF et al (2005) Do high-resolution CT findings of usual interstitial pneumonitis obviate lung biopsy? Views of pulmonologists. Respiration 72:134
51. Soler P, Bergeron A, Kambouchner M et al (2000) Is high-resolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis? Am J Respir Crit Care Med 162:264
52. Arzoo K, Sadeghi S, Pullarkat V (2001) Pa mi dro-na te for bone pain from osteolytic lesions in Lan-ger hans'-cell histiocytosis (letter). N Engl J Med 345:225
53. Farran RP, Zaretski E, Egeler RM (2001) Treatment of Langerhans cell histiocytosis with pa mi-dro nate. J Pediatr Hematol Oncol 23:54
54. Brown RE (2001) Bisphosphonates as antialveolar macrophage therapy in pulmonary Langerhans cell histiocytosis? Med Pediatr Oncol 36:641
55. Fernández-Latorre F, Menor-Serrano F, Alonso-Charterina S, Arenas-Jiménez J (2000) Langerhans' cell histiocytosis of the temporal bone in pe-diatric patients. AJR Am J Roentgenol 174: 217-221
56. Kamimura M, Kinoshita T, Itoh H et al (2000) Eosinophilic granuloma of the spine: early spontaneous disappearance of tumor detected on magnetic resonance imaging. J Neurosurg 93[2 Suppl]: 312-316
57. Guzey FK, Bas NS, Emel E et al (2003) Polyostotic monosystemic calvarial and spinal Langerhans cell histiocytosis treated by surgery and chemotherapy. Pediatr Neurosurg 38:206-211
58. Egeler RM, Thompson RC, Voûte PA, Nesbit ME (1992) Intralesional infiltration of corticosteroids in localized Langerhans cell histiocytosis. J Pediatr Orthop 12:811-814
59. Weitzman S, Egeler RM (2008) Langerhans cell histiocytosis: update for the pediatrician. Curr Opin Pediatr 20:23-29
60. Munn S, Chu AC (1998) Langerhans cell histiocytosis of the skin. Hematol Oncol Clin North Am 12:269-286
61. Kapur P, Erickson C, Rakheja D et al (2007) Congenital self-healing reticulohistiocytosis (Has hi-mo to-Pritzker disease): ten-year experience at Da llas Children's Medical Center. J Am Acad Dermatol 56:290-294
62. Braier J, Chantada G, Rosso D et al (1999) Langerhans cell histiocytosis: Retrospective evaluation of 123 patients at a single institution. Pediatr Hematol Oncol 16:377-385
63. Willis B, Ablin A, Weinberg V et al (1996) Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol 14: 2073-2082
64. Haupt R, Nanduri V, Calevo MG et al (2004) Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 42:438-444
65. The French Langerhans' Cell Histiocytosis Study Group (1996) A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 75:17-24
66. Mittheisz E, Seidl R, Prayer D (2007) Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis. Pediatr Blood Cancer 48:50-56
67. Maghnie M, Cosi G, Genovese E et al (2000) Central diabetes insipidus in children and young adults. N Engl J Med 343:998-1007
68. Municchi G, Marconcini S, D'Ambrosio A et al (2002) Central precocious puberty in multisystem Langerhans cell histiocytosis: a case report. Pediatr Hematol Oncol 19:273-278
69. Kaltsas GA, Powles TB, Evanson J et al (2000) Hypothalamo-pituitary abnormalities in adult patients with Langerhans cell histiocytosis: clinical, endocrinological and radiological features and response to treatment. J Clin Endocr Metab 85: 1370-1376
70. Maghnie M, Cosi G, Genovese E et al (2000) Cen tral diabetes insipidus in children and young adults. N Engl J Med 343:998
71. Maghnie M, Bossi G, Klersy C et al (1998) Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood Langerhans cell histiocytosis. J Clin Endocrinol Metab 83:3089
72. Braunstein GD, Kohler PO (1972) Pituitary function in Hand Shuller Christian disease. N Engl J Med 286:1225-1229
73. Dean HJ, Bishop A, Winter JS (1986) Growth hormone deficiency in patients with histiocytosis X. J Pediatr 109:615-618
74. Nanduri VR, Bareille P, Pritchard J, Stanhope R (1986) Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol (Oxf) 53:509-515
75. Donadieu J, Rolon MA, Pion I et al (2004) Incidence of growth hormone deficiency in pediatriconset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment. J Clin Endocrinol Metab 89:604-609
76. Lahey ME (1975) Histiocytosis X: An analysis of prognostic factors. J Pediatr 87:184-189
77. Komp DM, Herson J, Starling KA et al (1981) A staging system for Histiocytosis X: A Southwest Oncology Group Study. Cancer 47:798-800
78. Montella L, Insabato L, Palmieri G (2004) Imatinib mesylate for cerebral Langerhans'-cell histiocytosis. N Engl J Med 351:1034
79. Saven A, Foon KA, Piro LD (1994) 2-Chlo ro de o-xy adenosine-induced complete remissions in Lan-ger hans-cell histiocytosis. Ann Intern Med 121:430
80. Weitzman S, Wayne AS, Arceci R et al (1999) Nucleoside analogues in the therapy of Langerhans cell histiocytosis: a survey of members of the histiocyte society and review of the literature. Med Pediatr Oncol 33:476
81. Pardanani A, Phyliky RL, Li CY, Tefferi A (2003) 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clin Proc 78:301
82. Womer RB, Anunciato KR, Chehrenama M (1995) Oral methotrexate and alternate-day prednisone for low-risk Langerhans cell histiocytosis. Med Pediatr Oncol 25:70-73
83. Munn SE, Olliver L, Broadbent V, Pritchard J (1999) Use of indomethacin in Langerhans cell histiocytosis. Med Pediatr Oncol 32:247-249
84. Farran RP, Zaretski E, Egeler RM (2001) Treatment of Langerhans cell histiocytosis with pamidronate. J Pediatr Hematol Oncol 23:54-56
85. Rodriguez-Galindo C, Kelly P, Jeng M et al (2002) Treatment of children with Langerhans Cell Histiocytosis with 2-Chlorodeoxyadenosine. Am J Hematol 69:179-184
86. Choi SW, Bangaru BS, Wu CD, Finlay JL (2003) Gastrointestinal involvement in disseminated Langerhans cell histiocytosis with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine. J Pediatr Hematol Oncol 25:503-506
87. Steiner M, Mathes-Martin S, Attarbaschi A et al (2005) Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant 36:215-225
88. Mogulkoc N, Veral A, Bishop PW et al (1999) Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation. Chest 115:1452
89. Reichle A, Vogt T, Kunz-Schughart L et al (2005) Anti-inflammatory and angiostatic therapy in chemorefractory multisystem Langerhans' cell histiocytosis of adults. Br J Haematol 128:730